Next Generation Cancer Vaccine Development Summit

Chief Scientific Officer, Vaccibody

Scientific Director, Head of Cancer Vaccines, Janssen

Assistant Professor, The University off Texas MD Anderson Cancer Center

Head of Preclinical and Clinical Immunology, Nouscom

Senior Scientist & Group Leader, Genentech

Clinical Director, Center for Neuro- Oncology, Dana-Faber Cancer Institute

Director, Dodson Interdisciplinary Immunotherapy Institute, University of Miami

Chief Executive Officer, PDC*line Pharma

Chief Scientific Officer, 3T Biosciences

Group Leader, BioNanoSciences – Drug Delivery and Immunotherapy, University of Lisbon

Director Pre-clinical Development, Genocea Biosciences

Chief Scientific Officer, Genocea Biosciences

Global Head of MTS Business Development & Senior Research Immunologist, Kindeva

Chief Scientific Officer, Gritstone Oncology

Principal Scientist, Cancer Immunology, Genentech

Director Cancer Vaccines, BioNTech

Executive Director, Research Biochemistry, Agenus Bio

Chief Executive Officer, MimiVax

Chief Executive Officer, Nicholas Pharmaceuticals

CEO, Geneos

Chief Executive Officer, Grey Wolf Therapeutics

Head of pDNA/mRNA Process Development, BIA Separations, a Sartorius Company

Head, Cancer Research and Nanomedicine Laboratory Tel Aviv University

Division of Oncology, Washington University School of Medicine

Chief Medical Officer, Genocea Biosciences

Chief Scientific Officer, Targovax

Chief Scientific Officer, Frame Therapeutics

Senior Postdoctoral Fellow, Netherlands Cancer Institute

VP, Clinical Science, Gritstone

Medical Director, Immuno-Onocology Clinical Development, Inovio Pharmaceuticals

University of Torino, Italy

CIPF, Spain

Director, Dodson Interdisciplinary Immunotherapy Institute, University of Miami